Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Within-host evolution of SARS-CoV-2 in an immunosuppressed COVID-19 patient as a source of immune escape variants
Sebastian Weigang, Jonas Fuchs, Gert Zimmer, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 167

Showing 26-50 of 167 citing articles:

A comparison of four epidemic waves of COVID-19 in Malawi; an observational cohort study
Catherine Anscombe, Samantha Lissauer, Herbert Thole, et al.
BMC Infectious Diseases (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 17
Host-microbe multiomic profiling reveals age-dependent immune dysregulation associated with COVID-19 immunopathology
Hoang Van Phan, Alexandra Tsitsiklis, Cole Maguire, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 743
Open Access | Times Cited: 6
Chronic COVID-19 infection in an immunosuppressed patient shows changes in lineage over time: a case report
Sheridan J.C. Baker, Landry Nfonsam, Daniela Leto, et al.
Virology Journal (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 5
Antigenicity assessment of SARS-CoV-2 saltation variant BA.2.87.1
Sijie Yang, Yuanling Yu, Fanchong Jian, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 5
SARS-CoV-2 excretion and genetic evolution in nasopharyngeal and stool samples from primary immunodeficiency and immunocompetent pediatric patients
Haifa Khemiri, Ilhem Ben Fraj, Alessio Lorusso, et al.
Virology Journal (2025) Vol. 22, Iss. 1
Open Access
Hybrid versus vaccine immunity of mRNA-1273 among people living with HIV in East and Southern Africa: a prospective cohort analysis from the multicentre CoVPN 3008 (Ubuntu) study
Nigel Garrett, Asa Tapley, Aaron Hudson, et al.
EClinicalMedicine (2025) Vol. 80, pp. 103054-103054
Closed Access
The impact of remdesivir on SARS-CoV-2 evolution in vivo
Ted Ling-Hu, Lacy M. Simons, Estefany Rios-Guzman, et al.
JCI Insight (2025)
Open Access
Humoral responses to SARS-CoV-2 vaccine in vasculitis-related immune suppression
Kimia Kamelian, Benjamín L. Sievers, Michael Chen‐Xu, et al.
Science Advances (2025) Vol. 11, Iss. 7
Open Access
Duration of SARS-CоV-2 virus shedding in COVID-19 patients with HIV infection
Dmitry Lioznov, О. Е. Pobegalova, N. V. Sabadash, et al.
HIV Infection and Immunosuppressive Disorders (2025) Vol. 16, Iss. 4, pp. 99-106
Open Access
Evolution of SARS-CoV-2 in Spain during the First Two Years of the Pandemic: Circulating Variants, Amino Acid Conservation, and Genetic Variability in Structural, Non-Structural, and Accessory Proteins
Paloma Troyano-Hernáez, Roberto Reinosa, África Holguín
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 12, pp. 6394-6394
Open Access | Times Cited: 25
Ubiquitin variants potently inhibit SARS-CoV-2 PLpro and viral replication via a novel site distal to the protease active site
Vera Jannie Elisabeth van Vliet, Nhan Huynh, Judith Palà, et al.
PLoS Pathogens (2022) Vol. 18, Iss. 12, pp. e1011065-e1011065
Open Access | Times Cited: 23
Evolution of a globally unique SARS-CoV-2 Spike E484T monoclonal antibody escape mutation in a persistently infected, immunocompromised individual
Peter Halfmann, Nicholas R. Minor, Luis A. Haddock, et al.
Virus Evolution (2022) Vol. 9, Iss. 2
Open Access | Times Cited: 22
SARS-CoV-2-Specific T Cell Responses in Immunocompromised Individuals with Cancer, HIV or Solid Organ Transplants
David B. Reeg, Maike Hofmann, Christoph Neumann‐Haefelin, et al.
Pathogens (2023) Vol. 12, Iss. 2, pp. 244-244
Open Access | Times Cited: 14
Molecular Epidemiology and Diversity of SARS-CoV-2 in Ethiopia, 2020–2022
Abay Sisay, Derek Tshiabuila, Stephanie van Wyk, et al.
Genes (2023) Vol. 14, Iss. 3, pp. 705-705
Open Access | Times Cited: 14
Analysis of well-annotated next-generation sequencing data reveals increasing cases of SARS-CoV-2 reinfection with Omicron
Scott Burkholz, Michael Rubsamen, Luke Blankenberg, et al.
Communications Biology (2023) Vol. 6, Iss. 1
Open Access | Times Cited: 12
Rapid intra-host diversification and evolution of SARS-CoV-2 in advanced HIV infection
Sung Hee Ko, Pierce Radecki, Frida Belinky, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 4
Strong T-cell activation in response to COVID-19 vaccination in multiple sclerosis patients receiving B-cell depleting therapies
Roberto Alfonso, Y. S. Lin, Vanessa Kirschner, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 20
Duration of SARS-CoV-2 shedding and infectivity in the working age population: a systematic review and meta-analysis
Alborz Rahmani, Guglielmo Dini, Veruscka Leso, et al.
˜La œMedicina del lavoro (2022) Vol. 113, Iss. 2, pp. e2022014-e2022014
Open Access | Times Cited: 19
Human coronaviruses: The emergence of SARS-CoV-2 and management of COVID-19
Magan Solomon, Chen Liang
Virus Research (2022) Vol. 319, pp. 198882-198882
Open Access | Times Cited: 19
The impact of sphingosine-1-phosphate receptor modulators on COVID-19 and SARS-CoV-2 vaccination
David Baker, Eugenia Forte, Gareth Pryce, et al.
Multiple Sclerosis and Related Disorders (2022) Vol. 69, pp. 104425-104425
Open Access | Times Cited: 19
Viral cultures, cycle threshold values and viral load estimation for assessing SARS-CoV-2 infectiousness in haematopoietic stem cell and solid organ transplant patients: a systematic review
Tom Jefferson, Elizabeth Spencer, John Conly, et al.
Journal of Hospital Infection (2022) Vol. 132, pp. 62-72
Open Access | Times Cited: 19
Delta-Omicron recombinant escapes therapeutic antibody neutralization
Ralf Duerr, Hao Zhou, Takuya Tada, et al.
iScience (2023) Vol. 26, Iss. 2, pp. 106075-106075
Open Access | Times Cited: 11
Total escape of SARS-CoV-2 from dual monoclonal antibody therapy in an immunocompromised patient
Lena Jaki, Sebastian Weigang, Lisa Kern, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 11
Combining CRISPR-Cas-mediated terminal resolution with a novel genetic workflow to achieve high-diversity adenoviral libraries
Julian Fischer, Ariana Fedotova, Lena Jaki, et al.
Molecular Therapy — Methods & Clinical Development (2024) Vol. 32, Iss. 2, pp. 101241-101241
Open Access | Times Cited: 3
Coronavirus Disease-2019 in the Immunocompromised Host
Christopher D. Bertini, Fareed Khawaja, Ajay Sheshadri
Clinics in Chest Medicine (2022) Vol. 44, Iss. 2, pp. 395-406
Open Access | Times Cited: 18

Scroll to top